MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » The MassDevice Weekly Checkup: July 25, 2011

The MassDevice Weekly Checkup: July 25, 2011

By

Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.

The MassDevice Indices are weighted according to market capitalization, based on the number of shares outstanding for each company and each Friday’s closing share price.

MassDevice index Massachusetts
The Massachusetts index for the week ended July 22 closed at 6.41, exactly flat compared with the prior week. Since Jan. 1, 2009, when we began tracking these companies, the index has risen 44.7 percent.

MassDevice index Minnesota
The Minnesota index for the week ended July 22 closed at 37.8, up 4.7 percent compared with the prior week. Since Jan. 1, 2009, when we began tracking these companies, the index has risen 37.8 percent.

MassDevice index California
The California index for the week ended July 22 closed at 12.20, up 3.9 percent compared with the prior week. Since Jan. 1, 2009, when we began tracking these companies, the index has risen 156.3 percent [Eds. note: This wee we updated our California index to reflect the acquisitions of Cardiogenesis Corp., Clarient Inc., Emergent Group Inc. (PDF), Micrus Endovascular Corp. and SenoRx Inc. This accounts for the index’s increase this week, and for the increase reflected below in the composite MassDevice Index].

We also create a composite index of the three regional indices and compare it with four other indices (the S&P 500, the Dow Jones Industrial Average, the Dow’s IHI medical devices index and the NASDAQ exchange):

MassDevice index composite

The Weekly Checkup also compares Monday morning’s opening share prices with their value when the markets close Friday afternoon to calculate the biggest gainers and losers.

Here are the 20 firms that posted the biggest share price gains and losses during the week ended July 22:

The 10 biggest gainers:

  1. Pressure BioSciences Inc.: 17.65% (open $0.68; close $0.8)
  2. World Heart Inc. : 16.67% (open $0.84; close $0.98)
  3. AdvanSource Biomaterials Corp.: 12.5% (open $0.08; close $0.09)
  4. Cambridge Heart Inc.: 11.11% (open $0.18; close $0.2)
  5. HepaLife Technologies: 7.87% (open $0.089; close $0.096)
  6. Athenahealth Inc.: 5.72% (open $54; close $57.09)
  7. Pro-Dex Inc. : 4.06% (open $1.97; close $2.05)
  8. Cerus Corp. : 3.89% (open $2.83; close $2.94)
  9. Enteromedics Inc. : 2.22% (open $2.7; close $2.76)
  10. Ophthalmic Imaging Systems : 2.17% (open $0.92; close $0.94)

Sources: Google Finance and Yahoo! Finance.

arrow-downAnd the 10 biggest losers:

  1. Trimedyne Inc. : -13.79% (open $0.145; close $0.125)
  2. Alphatec Holdings Inc. : -8.17% (open $3.55; close $3.26)
  3. Oculus Innovative Sciences Inc. (Micromed): -7.56% (open $1.72; close $1.59)
  4. American Shared Hospital Services : -7.27% (open $3.3; close $3.06)
  5. Edwards Lifesciences Corp. : -5.62% (open $82.55; close $77.91)
  6. CR Bard Inc.: -4.18% (open $103.92; close $99.58)
  7. Masimo Corp. (Masimo Americas) : -3.34% (open $30.83; close $29.8)
  8. Biomerica Inc. : -3.33% (open $0.45; close $0.435)
  9. Cytori Therapeutics Inc. : -3.08% (open $4.87; close $4.72)
  10. Synovis Life Technologies Inc. : -2.93% (open $18.41; close $17.87)

Sources: Google Finance and Yahoo! Finance.

Disclaimer: MassDevice.com’s rankings do not reflect an opinion of companies’ health, prospects or viability. They are intended to provide a snapshot of publicly traded medical device companies and in no way constitute a recommendation to buy or sell any particular security, portfolio of securities, transaction or investment strategy.

In case you missed it

RSS From Medical Design & Outsourcing

  • FDA can’t explain drop in device recalls, but experts point to COVID disruptions
    The FDA acknowledged interruptions with notifications from recalling firms during the pandemic, while regulatory experts point to fewer inspections and fewer procedures. FDA medical device product recalls dropped last year to their lowest level since 2013, according to a Medical Design & Outsourcing analysis of recall data from the regulatory agency. Medtech regulatory experts said the COVID-19… […]
  • DeviceTalks Boston 2022: Here’s what you missed on the show floor
    At DeviceTalks Boston 2022, there was a wealth of expertise to be had from exhibitors including Viant, ICS, PSN Labs, Propel and more. From stories of overcoming challenges during the COVID-19 pandemic to medical device materials pitfalls to avoid, MassDevice and MDO executive editor Chris Newmarker hit the DeviceTalks Boston show floor to discover insights. […]
  • Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future
    All eyes are on Medtronic’s global operations and supply chain leader as he works to modernize its operations and scrutinize suppliers. EVP of Global Operations and Supply Chain Greg Smith anticipates fewer suppliers in Medtronic’s future, he said in an interview this week. Smith spoke with DeviceTalks Editorial Director Tom Salemi in his first published… […]
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
    CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable… […]
  • Meddux opens new facility in Colorado
    Engineering, design, development and manufacturing company Meddux announced that it opened a new facility in Boulder, Colorado. The new, 22,000-square-foot facility doubles the overall square footage from its previous location in Colorado. According to a news release, it helps the company to quadruple its product development area and double its manufacturing footprint. Meddux’s new facility… […]
  • Reducing the Overall Cost of Validation
    By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
  • BBS Automation has a deal to buy medtech supplier Kahle Automation
    BBS Automation said it plans to purchase high-speed automation supplier Kahle Automation to expand its medtech and life sciences business. Kahle will operate as Kahle – a BBS Company, according to a news release from Munich, Germany-based BBS and Lombardy, Italy-based Kahle. The deal is subject to regulatory approval. Terms were not disclosed. Kahle’s co-owners —… […]
  • How safe is health information after the overturning of Roe?
    The U.S. Department of Health and Human Services today issued guidance meant to better protect women’s health information as state abortion bans kick in after the U.S. Supreme Court’s overturning of Roe v. Wade. Despite the HHS actions, women may still wonder whether their health information is entirely safe going forward — a potential challenge… […]
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
    New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s… […]
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
    Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt… […]
  • How medical device companies are responding to abortion bans
    Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]